Paper Details

  1. Home
  2. Paper Details

Preliminary results of beta-interferon treatment in the elderly.

Author: LucaS, TerranovaR

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

In a study of 26 people with chronic hepatitis C, those who received beta-interferon treatment showed improved liver function and clinical symptoms in 54% of cases. However, the disease returned in 57% of these patients within 12 months after stopping treatment.
Paper Details　
Original Abstract of the Article :
The authors studied 26 patients presenting with chronic hepatitis C who were diagnosed by clinical and histological tests. Thirteen patients were treated with beta-interferon (3 x 10(6) IM for 2 months and consecutive 6 x 10(6) IM for 10 months) every second evening, while the remaining 13 received ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0197-2456(96)80004-3

データ提供：米国国立医学図書館（NLM）

Beta-Interferon Treatment in the Elderly: A Glimpse into the Desert of Hepatitis C

This research explores the effectiveness of beta-interferon treatment in older adults with chronic hepatitis C, a viral infection that can cause liver damage and inflammation. Imagine a traveler in a desert, seeking a remedy for a persistent illness. The researchers evaluated the effects of beta-interferon on a group of elderly patients with hepatitis C, hoping to find a way to heal and restore balance.

A Potential Treatment for Hepatitis C in the Elderly

This research offers hope for older adults with chronic hepatitis C, suggesting that beta-interferon may be a valuable treatment option. The authors found that beta-interferon led to improvement in liver function and clinical symptoms in a significant number of patients.

Navigating the Desert of Hepatitis C

This research provides valuable insights into the management of hepatitis C in older adults, offering a potential avenue for treatment and improved quality of life. Imagine a traveler finding a hidden oasis, offering relief and a path towards recovery. The authors' findings suggest that beta-interferon may be a valuable tool for managing this disease in the elderly.

Dr. Camel's Conclusion

This research is like a journey through a vast desert, where the challenges of hepatitis C can be addressed with the right tools and strategies. The authors' findings suggest that beta-interferon may offer a glimmer of hope for older adults with this persistent illness. This research reminds us that even in the most challenging of landscapes, there are opportunities for healing and restoration.
Date :
  1. Date Completed 1997-05-05
  2. Date Revised 2019-10-24
Further Info :

Pubmed ID

8860065

DOI: Digital Object Identifier

10.1016/s0197-2456(96)80004-3

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.